VIVO BIO TECH LTD. has reported Consolidated financial results for the period ended June 30, 2023.
Financial Results (Q1 FY2024) - QoQ Comparison
The company has reported total income of Rs. 11.5821 crores during the period ended June 30, 2023 as compared to Rs. 14.7787 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs. 0.1424 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 2.0632 crores for the period ended March 31, 2023.
The company has reported EPS of Rs. 0.10 for the period ended June 30, 2023 as compared to Rs. 1.38 for the period ended March 31, 2023.
Total Income | ₹ 11.5821 crs | ₹14.7787 crs | -21.63% |
Net Profit | ₹0.1424 crs | ₹2.0632 crs | -93.10% |
EPS | ₹0.10 | ₹1.38 | -92.75% |
Financial Results (Q1 FY2024) - YoY Comparison The company has reported total income of Rs. 11.5821 crores during the period ended June 30, 2023 as compared to Rs.11.2642 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs.0.1424 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.0.3160 crores for the period ended June 30, 2022.
The company has reported EPS of Rs.0.10 for the period ended June 30, 2023 as compared to Rs.0.22 for the period ended June 30, 2022.
Total Income | ₹ 11.5821 crs | ₹11.2642 crs | 2.82% |
Net Profit | ₹0.1424 crs | ₹0.3160 crs | -54.94% |
EPS | ₹0.10 | ₹0.22 | -54.55% |
Shares of VIVO BIO TECH LTD. was last trading in BSE at Rs. 30.30 as compared to the previous close of Rs. 29.74. The total number of shares traded during the day was 17368 in over 97 trades.
The stock hit an intraday high of Rs. 31.30 and intraday low of 30.00. The net turnover during the day was Rs. 527978.00.
Source : Equity Bulls
Keywords
VivoBioTech
Q1FY24
ResultUpdate